We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
Cap. Flow
-$129M
Cap. Flow %
-0.3%
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$78.2M
2
AMZN icon
Amazon
AMZN
+$74.6M
3
CSCO icon
Cisco
CSCO
+$69.3M
4
MNST icon
Monster Beverage
MNST
+$68.9M
5
ORCL icon
Oracle
ORCL
+$67.9M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$449M
2
AGN.PRA
Allergan plc
AGN.PRA
+$175M
3
AZO icon
AutoZone
AZO
+$87M
4
VREX icon
Varex Imaging
VREX
+$49M
5
CVS icon
CVS Health
CVS
+$44M

Sector Composition

Rank Sector Weight
1 Technology 17.75%
2 Consumer Discretionary 15.19%
3 Healthcare 12.92%
4 Financials 12.83%
5 Communication Services 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWL icon
751
Powell Industries
POWL
$7.7B
$13K ﹤0.01%
1,242
+531
+75% +$5.9K
RF icon
752
Regions Financial
RF
$27.3B
$13K ﹤0.01%
904
-600
-40% -$8.45K
UMPQ
753
DELISTED
Umpqua Holdings Corp
UMPQ
$13K ﹤0.01%
733
+237
+48% +$4.2K
BRKR icon
754
Bruker
BRKR
$7.66B
$12K ﹤0.01%
+409
New +$10.5K
XOXO
755
DELISTED
Xo Group Inc
XOXO
$12K ﹤0.01%
707
+558
+374% +$9.6K
CWEN icon
756
Clearway Energy Class C
CWEN
$4.94B
$11K ﹤0.01%
605
+47
+8% +$823
FORR icon
757
Forrester Research
FORR
$228M
$11K ﹤0.01%
284
HLF icon
758
Herbalife
HLF
$1.33B
$11K ﹤0.01%
318
-222
-41% -$7.48K
MEDP icon
759
Medpace
MEDP
$16.1B
$11K ﹤0.01%
393
+46
+13% +$1.29K
NHTC icon
760
Natural Health Trends
NHTC
$15.4M
$11K ﹤0.01%
+397
New +$11.3K
PAHC icon
761
Phibro Animal Health
PAHC
$1.48B
$11K ﹤0.01%
287
CRVL icon
762
CorVel
CRVL
$3.01B
$10K ﹤0.01%
612
-93
-13% -$1.41K
NWN icon
763
Northwest Natural Holdings
NWN
$2.05B
$10K ﹤0.01%
+173
New +$10.5K
NUVA
764
DELISTED
NuVasive, Inc.
NUVA
$10K ﹤0.01%
127
CHE icon
765
Chemed
CHE
$7.05B
$9K ﹤0.01%
45
-149
-77% -$29.7K
FCNCA icon
766
First Citizens BancShares
FCNCA
$25.6B
$9K ﹤0.01%
24
HPE icon
767
Hewlett Packard
HPE
$69.4B
$9K ﹤0.01%
706
-1,200
-63% -$16.7K
LPX icon
768
Louisiana-Pacific
LPX
$5.37B
$9K ﹤0.01%
+367
New +$8.94K
MOH icon
769
Molina Healthcare
MOH
$9.99B
$9K ﹤0.01%
123
-6
-5% -$368
MTG icon
770
MGIC Investment
MTG
$6.35B
$9K ﹤0.01%
839
-2,150
-72% -$23.1K
RGEN icon
771
Repligen
RGEN
$8.45B
$9K ﹤0.01%
223
SAFM
772
DELISTED
Sanderson Farms Inc
SAFM
$9K ﹤0.01%
79
-258
-77% -$30K
WP
773
DELISTED
Worldpay, Inc.
WP
$9K ﹤0.01%
+144
New +$9.04K
CI icon
774
Cigna
CI
$72.4B
$8K ﹤0.01%
+46
New +$7.39K
CLW icon
775
Clearwater Paper
CLW
$369M
$8K ﹤0.01%
171
-356
-68% -$17.2K

Similar funds

Loomis, Sayles & Company's Q2 2017 Portfolio in Review

As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
  • Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
  • Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
  • Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
  • Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
  • Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
  • Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.